Robert Biddlecombe
Papers
5
Total Citations
385
H-Index
5
About
Robert Biddlecombe is a pioneering bioanalytical chemist whose work has fundamentally shaped high-throughput drug analysis in pharmaceutical research. His research centers on liquid chromatography-tandem mass spectrometry (LC-MS/MS), solid phase extraction, and the development of automated bioanalytical methods for quantifying drugs and their metabolites in biological matrices. Biddlecombe's most influential contribution — a 1996 paper garnering 116 citations — introduced automated 96-well format solid phase extraction coupled with LC-MS/MS, dramatically accelerating the throughput of bioanalysis for clinical drug development. This methodological innovation transformed how pharmaceutical scientists process large sample volumes, making large-scale clinical trials more analytically feasible. Building on this foundation, he advanced chiral separation techniques to distinguish drug enantiomers such as salbutamol and its metabolites (86 citations), an achievement with direct implications for understanding stereoselective pharmacokinetics. His 1999 work on automated protein precipitation in the 96-well format (82 citations) further streamlined sample preparation workflows. Perhaps most ambitiously, Biddlecombe pushed the boundaries further by demonstrating 384-well format SPE, envisioning what he memorably termed "a clinical trial on a plate." Collectively, his contributions have left an enduring mark on pharmaceutical bioanalysis, equipping researchers with faster, more sensitive tools for drug development.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3Automated protein precipitation by filtration in the 96-well format82 citations · 1999
- 4
- 5